Data Foundry

Drug recalls 2026

Argatroban Injection — Class I drug recall D-0083-2027

Ongoing recall by Par Health USA, LLC, reported 2026-10-28, distributed nationwide. Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainle

Recall numberD-0083-2027
Product typeDrug
ClassificationClass I
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmPar Health USA, LLC, Rochester, MI, United States
Recall initiated2026-10-13
Classified2026-10-26
Reported by FDA2026-10-28
DistributedNationwide (US)
Quantity1,944 vials
Reason classesspecification failure
NDC42023-0182, 42023-0182-89
Lot numbers84193, 92880
Expiration dates2026-10, 2027-08

Product

Argatroban Injection, USP, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Manufactured for: Endo USA, Malvern,PA 19355/ Argatroban Injection, 250 mg/2.5mL (100 mg/mL), 2.5 mL x 1 Single Dose Vial, Rx only, Distributed by: Par Pharmaceutical, Cranbury, NJ 08512, NDC 42023-182-89.

Reason for recall

Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0083-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-03. Not affiliated with or endorsed by FDA. Not medical or legal advice.